Here’s how investing £10 a day could create passive income of £27,573 a year!

Charlie Carman explains how he’d build a sizeable passive income portfolio over time by investing a tenner a day in dividend stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Passive income text with pin graph chart on business table

Image source: Getty Images

Buying dividend shares is a simple strategy investors can follow to generate passive income. Not only do they provide shareholders with regular cash payouts, but they also offer potential capital growth.

The average annual post-tax UK salary is £27,573 according to the latest ONS figures. I think it’s possible to generate that sum in dividend payouts by investing as little as £10 a day.

Here’s how I’d aim to achieve that goal.

Embracing risk

Dividend investing involves risks. Share prices can crash. Dividend income may not keep pace with inflation. Plus, dividend payments aren’t guaranteed since they can be cut or axed altogether.

Keeping a solid emergency fund in cash, carefully researching potential investments, and diversifying my portfolio across different companies and sectors are sensible ways of mitigating potential pitfalls.

However, ultimately investors need to become comfortable with risking their capital. After all, the other side of the coin is a potentially significant reward — a lifelong stream of substantial passive income.

Compound returns

So, how long would it take to earn £27,573 in annual passive income with £10 a day?

There’s no exact answer to this question. It’ll depend on my portfolio’s compound annual growth rate (CAGR) and the aggregated yield across my stock market holdings.

Currently, the average dividend yield for FTSE 100 stocks is 3.6%. Since I’d be investing exclusively in dividend shares, I’d aim for a higher overall yield of 5%.

That means I’d need a portfolio worth £551,460 to reach my target passive income stream. Even marginal improvements in my portfolio’s growth rate can drastically cut the time to build sufficient wealth, as the below table illustrates.

CAGRTime taken
4%49 years, 4 months
6%39 years, 2 months
8%33 years, 0 months
10%28 years, 8 months

Smart ways to boost my returns include reinvesting dividends and opting for commission-free brokers. I could also use a Stocks and Shares ISA to shelter my portfolio from the taxman or a SIPP for tax relief on my investments.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Dividend ideas

Now, let’s consider which dividend stocks investors like me could buy.

High-yield shares have an obvious appeal, but they’re often riskier than Dividend Aristocrats with solid distribution histories.

Other options include exchange-traded funds (ETFs) or real estate investment trusts (REITs). Of course, there are considerable advantages to investing in a diversified mix of all the above.

For example, one dividend stock I own is FTSE 100 pharma giant GSK (LSE:GSK).

There’s plenty about the company to excite value investors. Its forward price-to-earnings (P/E) ratio of 10.3 is much lower than that of major competitors like AstraZeneca.

In addition, the 3.7% dividend yield is decent enough and crucially, forecast cover of 2.6 times earnings suggests there’s a healthy margin of safety.

Granted, the business faces its fair share of challenges. A recent US court ruling has allowed 75,000 personal injury lawsuits against the firm to progress, which could expose it to costly awards. The claimants allege that GSK’s heartburn drug Zantac causes cancer.

Litigation difficulties aside, GSK recently upgraded its full-year guidance. Demand for the company’s blockbuster medications for shingles, HIV, and respiratory illnesses should remain strong regardless of economic cycles.

Overall, I think it’s a stock worth considering for a diversified passive income portfolio.

Charlie Carman has positions in AstraZeneca Plc and GSK. The Motley Fool UK has recommended AstraZeneca Plc and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Array of piggy banks in saturated colours on high colour contrast background
Investing Articles

5%+ dividend yields and P/Es below 11! 2 FTSE 100 shares to consider

The London stock market's bursting with bargains following recent choppiness. Here Royston Wild reveals two cheap FTSE stars that deserve…

Read more »

Diverse group of friends cheering sport at bar together
Investing Articles

8%+ yields! 2 investment trusts to target a £1,640 passive income this new ISA year

Considering these investment trusts could put ISA investors on the fast-track to a large and reliable long-term passive income. Royston…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

Looking for ISA bargains? 4 FTSE 250 value stars to consider

Just like Warren Buffett, I love snapping up quality stocks when they're marked down in price. Here are four top…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

£20,000 invested in AstraZeneca shares 5 years ago is now worth…

AstraZeneca shares have more than doubled since 2021 -- but they still look very undervalued. Here’s why forecast earnings growth…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

£10,000 invested in Micron stock six months ago is now worth…

Dr James Fox talks about Micron stock -- one of his best investments over the past six months. Does he…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

100%+ earnings growth and a P/E of 8.5? Could this be a once-in-a-decade stock market gift for value investors?

As the UK stock market makes a go at a recovery, Mark Hartley identifies one FTSE 250 stock that could…

Read more »

Investing Articles

Greggs shares are up 90% in a decade. What could the next decade bring?

Mark Hartley remains optimistic about his Greggs shares, citing long-term growth. But could they still offer an opportunity for value…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

5 steps towards a Stocks & Shares ISA worth £1m

Millions of Britons are missing out on wealth creation because they're not following these steps. Dr James Fox details how…

Read more »